CTL | cytotoxic T lymphocyte |
CTLA-4 | cytotoxic T lymphocyte antigen-4 |
PD-1 | programmed death 1 receptor |
PD-L1 | programmed death ligand 1 |
irAE | immune related adverse effect |
NSCLC | non-small cell lung cancer |
CTL | cytotoxic T lymphocyte |
CTLA-4 | cytotoxic T lymphocyte antigen-4 |
PD-1 | programmed death 1 receptor |
PD-L1 | programmed death ligand 1 |
irAE | immune related adverse effect |
NSCLC | non-small cell lung cancer |